BIZENGRI

Partner Therapeutics, Inc.

Formula & Concentration

BIZENGRI – zenocutuzumab-zbco 375 mg/18.75 mL (20 mg/mL) intravenous solution

Manufacturer

Partner Therapeutics, Inc.

Indications

BIZENGRI – zenocutuzumab-zbco 375 mg/18.75 mL (20 mg/mL) intravenous solution

Product Options

Package Size

NDC #

Presentation

375 MG/18.7

71837-1000-02

VIAL

Shelf Life and Storage

Fridge (2-8°C)